The data foundation for life science AI

From literature to label.
In one API.

Publications, genes, molecules, clinical trials, patents, and the full FDA & EMA record — one cross-linked Core graph your models and agents query through a single API.

live linkplanned

Click a core for its data at a glance — coverage, breakdowns, and the fields you can filter on

Get API key →Read the docs Build Assistant For AI agents

Find work by the two scientists most central to GLP-1 biology: Lotte Bjerre Knudsen (Novo Nordisk, designed semaglutide) and Daniel Drucker (Toronto, discovered GLP-1's incretin effect).

queryGLP-1 receptor agonist obesityincludeauthorsMetadataminPublicationDate2018-01-01authorNamesLotte Bjerre KnudsenDaniel Drucker

Request

GET https://api.amass.tech/api/v1/cores/biomedcore/records?query=GLP-1%20receptor%20agonist%20obesity&include=authorsMetadata&minPublicationDate=2018-01-01&authorNames=Lotte%20Bjerre%20Knudsen&authorNames=Daniel%20Drucker

Response · 200 OK

{
  "data": [
    {
      "amassId": "AMBC_RwzeOtqYiRA2S523v1jL81OgndQ",
      "pmid": "34626851",
      "pmcid": "PMC8859548",
      "doi": "10.1016/j.molmet.2021.101351",
      "title": "GLP-1 physiology informs the pharmacotherapy of obesity",
      "abstract": "BACKGROUND: 
Glucagon-like peptide-1 receptor agonists (GLP1RA) augment glucose-dependent insulin release and reduce glucagon secretion and gastric emptying, enabling their successful development for the treatment of type 2 diabetes (T2D).…",
      "authors": ["Daniel J. Drucker"],
      "journal": "Molecular metabolism",
      "issn": "2212-8778",
      "volumeIssue": "57",
      "language": "eng",
      "publicationDate": "2022-03-01",
      "publicationTypes": ["Journal Article", "Research Support, Non-U.S. Gov't", "Review"],
      "isRetracted": false,
      "citationCount": 423,
      "journalQualityJufo": 2,
      "meshTerms": ["Adolescent", "Animals", "Diabetes Mellitus, Type 2", "Glucagon-Like Peptide 1", "Glucagon-Like Peptide-1 Receptor", …],
      "keywords": ["Brain", "Diabetes", "G protein-coupled receptor", "Hunger", "Obesity", …],
      "substances": ["Glucagon-Like Peptide-1 Receptor", "Liraglutide", "Glucagon-Like Peptide 1"],
      "hasFulltext": false,
      "authorsMetadata": [
        {
          "name": "Daniel J. Drucker",
          "orcid": "0000-0001-6688-8127",
          "affiliations": [{ "name": "Lunenfeld-Tanenbaum Research Institute", "ror": "01s5axj25", "countryCode": "CA" }]
        }
      ],
      "meshIds": ["D000293", "D000818", "D003924", "D052216", "D000067757", …],
      "substanceIds": ["D000067757", "D000069450", "D052216"],
      "referencesTrialCore": [],
      "references": ["AMBC_5km7Q541cJN5a8RcTUN2tcgYoRj", "AMBC_WUubCFjk6wfURImFXwtDEvKquIE", "AMBC_3pwzL1urfguQm7s2L8Jlj04onOR", "AMBC_YDNDzsaB3vLPfxW6MNxdJU7vwI0", "AMBC_KH7wBl2Araj9gbLXuQWOHefvkIs", …],
      "citedBy": ["AMBC_B5CfpHBkdFha6MX0Q2GJpCBMw3o", "AMBC_UAflDqTKZtUAEny8XTtIvPvCWu7", "AMBC_P2sn7qrFvXfd8grl0s5scQ2El3t", "AMBC_5Er4ez0MRO1LsHzGpqflcUlzSFZ", "AMBC_PB5LfnIhIOOXiZLcXAokubVODU8", …]
    },
    { "pmid": "32987188", "title": "Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease", "citationCount": 270, … },
    { "pmid": "35907261", "title": "Glucagon-like Peptide-1 Receptor-based Therapeutics for Metabolic Liver Disease", "citationCount": 113, … },
    { "pmid": "41654015", "title": "Ectopic, hepatic GLP-1R agonism enhances the weight loss efficacy of GLP-1 analogues", "citationCount": 0, … },
    { "pmid": "29317623", "title": "GLP-1 release and vagal afferent activation mediate the beneficial metabolic and chronotherapeutic effects of D-allulose", "citationCount": 181, … }
  ]
}

40M+

Publications

43K+

Genes & targets

22K+

Molecules

1.2M+

Clinical trials

7K+

FDA + EMA authorizations

16M+

Patents

Cross-linked by design. Follow any paper to its targets, any target to its molecules, any molecule to its trials, and any trial back to the evidence.

Click any core in the graph above to see what's inside.

Build with the Amass *Cores

Get started

From API key to first response in minutes. Auth, requests, and parsing your first result.

Built for AI agents

A one-page reference your LLM can read top to bottom — drop it into a prompt and call the API.

Example workflows

End-to-end queries for literature review, pipeline tracking, and trial intelligence.

From literature to label.
In one API.

Publications, genes, molecules, clinical trials, patents, and the full FDA & EMA record — one cross-linked Core graph your models and agents query through a single API.

live linkplanned

Click a core for its data at a glance — coverage, breakdowns, and the fields you can filter on

{ "data": [ { "amassId": "AMBC_RwzeOtqYiRA2S523v1jL81OgndQ", "pmid": "34626851", "pmcid": "PMC8859548", "doi": "10.1016/j.molmet.2021.101351", "title": "GLP-1 physiology informs the pharmacotherapy of obesity", "abstract": "BACKGROUND: Glucagon-like peptide-1 receptor agonists (GLP1RA) augment glucose-dependent insulin release and reduce glucagon secretion and gastric emptying, enabling their successful development for the treatment of type 2 diabetes (T2D).…", "authors": ["Daniel J. Drucker"], "journal": "Molecular metabolism", "issn": "2212-8778", "volumeIssue": "57", "language": "eng", "publicationDate": "2022-03-01", "publicationTypes": ["Journal Article", "Research Support, Non-U.S. Gov't", "Review"], "isRetracted": false, "citationCount": 423, "journalQualityJufo": 2, "meshTerms": ["Adolescent", "Animals", "Diabetes Mellitus, Type 2", "Glucagon-Like Peptide 1", "Glucagon-Like Peptide-1 Receptor", …], "keywords": ["Brain", "Diabetes", "G protein-coupled receptor", "Hunger", "Obesity", …], "substances": ["Glucagon-Like Peptide-1 Receptor", "Liraglutide", "Glucagon-Like Peptide 1"], "hasFulltext": false, "authorsMetadata": [ { "name": "Daniel J. Drucker", "orcid": "0000-0001-6688-8127", "affiliations": [{ "name": "Lunenfeld-Tanenbaum Research Institute", "ror": "01s5axj25", "countryCode": "CA" }] } ], "meshIds": ["D000293", "D000818", "D003924", "D052216", "D000067757", …], "substanceIds": ["D000067757", "D000069450", "D052216"], "referencesTrialCore": [], "references": ["AMBC_5km7Q541cJN5a8RcTUN2tcgYoRj", "AMBC_WUubCFjk6wfURImFXwtDEvKquIE", "AMBC_3pwzL1urfguQm7s2L8Jlj04onOR", "AMBC_YDNDzsaB3vLPfxW6MNxdJU7vwI0", "AMBC_KH7wBl2Araj9gbLXuQWOHefvkIs", …], "citedBy": ["AMBC_B5CfpHBkdFha6MX0Q2GJpCBMw3o", "AMBC_UAflDqTKZtUAEny8XTtIvPvCWu7", "AMBC_P2sn7qrFvXfd8grl0s5scQ2El3t", "AMBC_5Er4ez0MRO1LsHzGpqflcUlzSFZ", "AMBC_PB5LfnIhIOOXiZLcXAokubVODU8", …] }, { "pmid": "32987188", "title": "Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease", "citationCount": 270, … }, { "pmid": "35907261", "title": "Glucagon-like Peptide-1 Receptor-based Therapeutics for Metabolic Liver Disease", "citationCount": 113, … }, { "pmid": "41654015", "title": "Ectopic, hepatic GLP-1R agonism enhances the weight loss efficacy of GLP-1 analogues", "citationCount": 0, … }, { "pmid": "29317623", "title": "GLP-1 release and vagal afferent activation mediate the beneficial metabolic and chronotherapeutic effects of D-allulose", "citationCount": 181, … } ] }

From literature to label.In one API.

From literature to label.In one API.

From literature to label.
In one API.

From literature to label.
In one API.